NACE Rev. 2.1 · Group · Section C
21.1 Manufacture of basic pharmaceutical products
- Level
- Group
- NACE Rev. 2
- 21.1
- National codes
- Same as NACE
- Active companies
- 645
What 21.1 covers
Eurostat publishes no separate explanatory note for this group; its scope is the sum of the classes listed below.
Also searched as
- pharma
- pharmaceutical
- biotech
- biotechnologie
- biotechnology
- bioteknologia
Plain-language terms that lookup_industry maps to this code or the codes under it.
Classes in 21.1
National codes for 21.1
Every EU country uses NACE Rev. 2.1 as its national classification, sometimes with an extra national level. Sections, divisions and groups are identical in every national version; national detail only starts below the 4-digit class.
| Country | Classification | Code | Local title |
|---|---|---|---|
| France | NAF 2025 INSEE | 21.1 Identical to NACE at this level | Fabrication de produits pharmaceutiques de base |
| Sweden | SNI 2025 Statistics Sweden (SCB) | 21.1 Identical to NACE at this level | Tillverkning av farmaceutiska basprodukter |
| Belgium | NACE-BEL 2025 Statbel | 21.1 Identical to NACE at this level | Vervaardiging van farmaceutische grondstoffen |
| Czech Republic | CZ-NACE 2025 Czech Statistical Office (ČSÚ) | 21.1 Identical to NACE at this level | Výroba základních farmaceutických výrobků |
| Finland | TOL 2025 Statistics Finland | 21.1 Identical to NACE at this level | Lääkeaineiden valmistus |
| Estonia | EMTAK 2025 Statistics Estonia | 21.1 Identical to NACE at this level | Põhifarmaatsiatoodete tootmine |
Local titles are the official NACE Rev. 2.1 translations; national tables can word them slightly differently. Belgium is shown with the Dutch title (French in the translations table).
21.1 in other EU languages
The official title of NACE 21.1 in each language version of NACE Rev. 2.1.
| Language | Title |
|---|---|
| French France (NAF), Belgium (NACE-BEL) | Fabrication de produits pharmaceutiques de base |
| German Germany (WZ), Austria (ÖNACE) | Herstellung von pharmazeutischen Grundstoffen |
| Swedish Sweden (SNI) | Tillverkning av farmaceutiska basprodukter |
| Finnish Finland (TOL) | Lääkeaineiden valmistus |
| Czech Czech Republic (CZ-NACE) | Výroba základních farmaceutických výrobků |
| Estonian Estonia (EMTAK) | Põhifarmaatsiatoodete tootmine |
| Dutch Belgium (NACE-BEL), Netherlands (SBI) | Vervaardiging van farmaceutische grondstoffen |
| Danish Denmark (DB) | Fremstilling af farmaceutiske råvarer |
| Spanish Spain (CNAE) | Fabricación de productos farmacéuticos de base |
| Italian Italy (ATECO) | Fabbricazione di prodotti farmaceutici di base |
| Polish Poland (PKD) | Produkcja podstawowych substancji farmaceutycznych |
| Portuguese Portugal (CAE) | Fabricação de produtos farmacêuticos de base |
What changed from NACE Rev. 2
Unchanged from Rev. 2NACE Rev. 2.1 replaced Rev. 2 in EU statistics from 2025, and national registers are recoding companies to it. These Rev. 2 codes map to 21.1, according to Eurostat’s official correspondence table:
-
Rev. 2 21.1 Manufacture of basic pharmaceutical products maps entirely here
Companies under 21.1
Active legal entities whose main activity is one of the 1 classes in 21.1, from the official business registers. Refreshed daily; sole traders are not included.
Total: 645. A dash means no companies with this main activity in the index yet.
Find 21.1 companies from Claude
EU Company Leads is an MCP server. Your agent resolves the industry with lookup_industry, then lists companies with search_companies, filtered by size, age, region and more.
1 · lookup_industry
{
"query": "pharma"
}
2 · search_companies
{
"nace_codes": [
"21.1"
],
"countries": [
"BE",
"FR"
],
"limit": 25
}
Questions about NACE 21.1
What is NACE 21.1?
NACE 21.1 is the group “Manufacture of basic pharmaceutical products” in NACE Rev. 2.1, the EU statistical classification of economic activities, part of division 21 (Manufacture of basic pharmaceutical products and pharmaceutical preparations), in section C (Manufacturing).
What is the national equivalent of NACE 21.1 in France, Sweden, Belgium, Czech Republic, Finland and Estonia?
The national versions of NACE Rev. 2.1 keep sections, divisions and groups unchanged, so 21.1 is also 21.1 in NAF 2025 (France), SNI 2025 (Sweden), NACE-BEL 2025 (Belgium), CZ-NACE 2025 (Czech Republic), TOL 2025 (Finland) and EMTAK 2025 (Estonia). National detail is only added below the 4-digit class.
What was the NACE Rev. 2 code for NACE 21.1?
The code is unchanged: NACE Rev. 2 21.1 (Manufacture of basic pharmaceutical products) maps one-to-one to 21.1 in NACE Rev. 2.1.
How many companies are registered under NACE 21.1?
EU Company Leads holds 645 active companies whose main activity is 21.1: Belgium 356, France 226, Sweden 22, Finland 16, Estonia 14, Czech Republic 11. Counts come from the official business registers and are refreshed daily; sole traders are not included.
Other groups in 21
Headings, explanatory notes, translations and the Rev. 2 → Rev. 2.1 correspondence: © European Union, Eurostat, NACE Rev. 2.1, licensed under CC BY 4.0; formatted and linked by EU Company Leads. Company counts: official national business registers.